Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties
Antibodies · 22.12.2025 · 15 (1) · 2
DOI: 10.3390/antib15010002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibodies, online erschienen am 22.12.2025. Verfasst von Alexandra Rak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Depatment of Virology and Immunology, Institute of Experimental Medicine, 197022 Saint Petersburg, Russia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Background/Objectives: Notwithstanding the declaration by the World Health Organization in May 2023 regarding the conclusion of the COVID-19 pandemic, new cases of this potentially lethal infection continue to be documented globally, exerting a sustained influence on the worldwide economy and social structures. Contemporary SARS-CoV-2 variants, while associated with a reduced propensity for severe acute pathology, retain the capacity to induce long-term post-COVID syndrome, including in ambulatory patient populations. This clinical phenomenon may be attributable to potential autoimmune reactions hypothetically triggered by antiviral antibodies, thereby underscoring the need for developing novel, universal vaccines against COVID-19. The nucleocapsid protein (N), being one of its most conserved and highly immunogenic components of SARS-CoV-2, presents a promising target for such investigative efforts. However, the protective role of anti-N antibodies, generated during natural infection or through immunization with N-based vaccines, alongside the potential adverse effects associated with their production, remains to be fully elucidated. In the present study, we aim to identify potential sites of homology in structures or sequences between the SARS-CoV-2 N protein and human antigens detected using hyperimmune sera against N protein obtained from mice, rabbits, and hamsters.
Methods
We employed Western blot analysis of lysates from human cell lines (MCF7, HEK293T, THP-1, CaCo2, Hep2, T98G, A549) coupled with mass spectrometric identification to assess the cross-reactivity of polyclonal and monoclonal antibodies generated against recombinant SARS-CoV-2 N protein with human self-antigens.
Results
We showed that anti-N antibodies developed in mice and rabbits exhibit pronounced immunoreactivity towards specific components of the human proteome. In contrast, anti-N immunoglobulins from hamsters showed no non-specific cross-reactivity with either hamster or human proteomic extracts because of the lack of autoreactivity or immunogenicity differences. Subsequent mass spectrometric analysis of the immunoreactive bands identified principal autoantigenic targets, which were predominantly heat shock proteins (including HSP90-beta, HSP70, mitochondrial HSP60, and HSPA8), histones (H2B, H3.1–3), and key metabolic enzymes (G6PD, GP3, PKM, members of the 1st family of aldo-keto reductases).
Conclusions
The results obtained herein highlight the differences in the development of anti-N humoral responses in humans and in the Syrian hamster model. These data provide a foundational basis for formulating clinical recommendations to predict possible autoimmune consequences in COVID-19 convalescents and are of critical importance for the rational design of future N protein-based, cross-protective vaccine candidates against novel coronavirus infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Depatment of Virology and Immunology, Institute of Experimental Medicine, 197022 Saint Petersburg, Russia.
- Department of Molecular Biology of Viruses, Smorodintsev Research Institute of Influenza, 197022 Saint Petersburg, Russia.
ORCID-Profile: Alexandra Rak, Yana Zabrodskaya, Pei-Fong Wong, Irina Isakova-Sivak
Förderung
- Russian Science Foundation
Zitieren
APA
Rak, A., Zabrodskaya, Y., Wong, P. F., & Isakova-Sivak, I. (2025). Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties. Antibodies, 15(1), 2. https://doi.org/10.3390/antib15010002
Vancouver
Rak A, Zabrodskaya Y, Wong PF, Isakova-Sivak I. Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties. Antibodies. 2025;15(1):2. doi:10.3390/antib15010002
BibTeX
@article{Rak2025,
author = {Rak, Alexandra and Zabrodskaya, Yana and Wong, Pei-Fong and Isakova-Sivak, Irina},
title = {Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties},
journal = {Antibodies},
year = {2025},
volume = {15},
number = {1},
pages = {2},
doi = {10.3390/antib15010002}
}
EUVIMED